BOSTON SCIENTIFIC CORP Operating Income Loss

• BOSTON SCIENTIFIC CORP showed an increase of +38.8% in Operating Income Loss from 2024 to 2025.
• This data is from BOSTON SCIENTIFIC CORP's annual report (Form 10-K), filed with the SEC on February 17, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2010: $251.00 million | Q4 2010: $349.00 million | Q1 2011: $322.00 million | Q2 2011: $237.00 million | Q3 2011: $174.00 million | Q1 2012: $196.00 million | Q2 2012: -$3.59 billion | Q3 2012: -$594.00 million | Q1 2013: -$330.00 million | Q2 2013: $220.00 million | Q3 2013: $103.00 million | Q1 2014: $197.00 million | Q2 2014: -$69.00 million | Q3 2014: $64.00 million | Q1 2015: $24.00 million | Q2 2015: $219.00 million | Q3 2015: -$299.00 million | Q1 2016: $293.00 million | Q2 2016: -$334.00 million | Q3 2016: $348.00 million | Q1 2017: $364.00 million | Q2 2017: $225.00 million | Q3 2017: $377.00 million | Q1 2018: $407.00 million | Q2 2018: $392.00 million | Q3 2018: $388.00 million | Q1 2019: $541.00 million | Q2 2019: $384.00 million | Q3 2019: $383.00 million | Q1 2020: $146.00 million | Q2 2020: -$71.00 million | Q3 2020: -$205.00 million | Q1 2021: $370.00 million | Q2 2021: $262.00 million | Q3 2021: $387.00 million | Q1 2022: $466.00 million | Q2 2022: $423.00 million | Q3 2022: $358.00 million | Q1 2023: $552.00 million | Q2 2023: $514.00 million | Q3 2023: $693.00 million | Q1 2024: $675.00 million | Q2 2024: $520.00 million | Q3 2024: $733.00 million | Q1 2025: $921.00 million | Q2 2025: $819.00 million | Q3 2025: $1.05 billion.
• Over the full 18 years of available data (2008 to 2025), BOSTON SCIENTIFIC CORP's Operating Income Loss has grown by 340.1%.
• Historical annual values: Fiscal year 2025: $3.61 billion | Fiscal year 2024: $2.60 billion | Fiscal year 2023: $2.34 billion | Fiscal year 2022: $1.65 billion | Fiscal year 2021: $1.20 billion | Fiscal year 2020: -$80.00 million | Fiscal year 2019: $1.52 billion | Fiscal year 2018: $1.51 billion | Fiscal year 2017: $1.29 billion | Fiscal year 2016: $447.00 million | Fiscal year 2015: -$283.00 million | Fiscal year 2014: -$301.00 million | Fiscal year 2013: $120.00 million | Fiscal year 2012: -$3.87 billion | Fiscal year 2011: $904.00 million | Fiscal year 2010: -$656.00 million | Fiscal year 2009: -$894.00 million | Fiscal year 2008: -$1.51 billion.
• Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: August 7, 2026